Impaired Intracellular Calcium Mobilization and NFATc1
Availability in Tolerant Anti-Insulin B Cells M aintenance of unresponsiveness to self-Ags, i.e., immune tolerance, is essential for the prevention of autoimmune disease. During B cell development in the bone marrow, clonal deletion and receptor editing remove many autoreactive B cells from the repertoire (1) (2) (3) . Engagement of the BCR by self-Ags with limited potential for aggregation does not cause deletion or editing; rather, it induces B cells to undertake a gene expression program that results in functional silencing and anergy (4) . This process may render tolerant B cells susceptible to activation-induced death (5) or impair their ability to compete for follicular niches (6) . The high prevalence of organ-specific autoimmune diseases (e.g., thyroiditis, type I diabetes, and pernicious anemia) and associated auto-Ab responses indicates that the tolerant state of B cells that recognize soluble self-Ags is highly vulnerable. Therefore, understanding how tolerance is maintained for self-Ags expressed at physiologic levels is key for developing strategies to prevent breaches in immune tolerance to specific auto-Ags.
The mechanisms that mediate tolerance for soluble self-proteins have been investigated largely using hen egg lysozyme (HEL) 3 as a model neo-self-Ag (4 -10) . In this transgene model (anti-HEL/ HEL), B cells that express high affinity (Ͼ10 9 M) anti-HEL receptors in the presence of soluble HEL reduce surface IgM expression and lose key BCR-induced signaling responses. These tolerant B cells are refractory to anti-IgM stimulation as demonstrated by the reduction of tyrosine kinase substrate phosphorylation and the failure to mobilize NF-B. Anergic anti-HEL B cells also show an increase in basal intracellular calcium concentration ([Ca 2ϩ ] i ) and fail to mobilize Ca 2ϩ following receptor aggregation (8) . A similar pattern of uncoupling of the BCR from downstream signaling pathways is observed in other tolerance models (11, 12) . Consistent with the notion that BCR-derived signals are required for the completion of B lymphocyte development in the periphery (13) , anergic B cells in many models of tolerance (anti-HEL/HEL, anti-dsDNA, and anti-Sm) share surface phenotypes of transitional B cells, suggesting that anergic cells undergo developmental arrest. This state is manifested by reduced CD23 expression on follicular B cells and by failure to generate marginal zone B cells (14 -18) . In these models, loss of tolerance is accompanied by a reversal of the developmental block (19 -22) . Therefore, the reliance of tolerance on loss of BCR signals that alter development cannot be separated from its dependence on signals that maintain Ag-specific unresponsiveness, and it is not clear how tolerance is sustained in the absence of arrested development.
B cells that harbor anti-insulin Ig transgenes (125Tg) are well suited for the study of auto-Ag-induced signals that are conducive to tolerance without a block in B cell development. The 125Tg model differs significantly from other tolerance models in that its BCR is derived from a breach of tolerance in the primary immune response of a normal BALB/c mouse to insulin (23) . In the anti-HEL model, the BCR is derived from hyperimmunization with a foreign Ag (7), and anti-DNA transgenics are derived from mice with established autoimmune disease (24) . Tolerance for B cells harboring such high-affinity self reactivity is highly effective in normal immune systems in which their development is arrested (5, 7, 19) . In contrast, although 125Tg B cells are anergic to BCR stimulation, they do not undergo developmental arrest (25) ; rather, they enter mature B cell subsets where they pose a risk by contributing to active immune responses. The presence of such B cells in the mature repertoire is consistent with the clinical observation that administration of autologous insulin routinely leads to the production of insulin Abs (26) . Thus, a key issue for preventing autoimmunity is to understand how the threshold for tolerance is governed in self-reactive B cells that escape developmental arrest.
Analysis of BCR signaling in 125Tg B cells reveals that tyrosine kinase substrate phosphorylation remains coupled to the BCR following stimulation with anti-IgM and that basal [Ca 2ϩ ] i is not increased. The most striking features of anti-insulin B cells are impaired mobilization of Ca 2ϩ from intracellular stores, reduced basal levels of NFATc1, and failure to induce NFATc1 mobilization following stimulation with anti-IgM or ionomycin. These findings contrast with other tolerance models such as anti-HEL, anti-DNA, and ARS/A1 and demonstrate that nonresponsiveness in mature B cells can be maintained without major alterations in BCR signaling. Our results indicate that anergy is not a fixed state but a continuum and, thus, not all anergic B cells share the same signaling profile. Furthermore, our data suggest that altered peripheral development is a feature of BCRs that are uncoupled from downstream signaling pathways.
Materials and Methods

Mice
The 125Tg mice used in this study harbor conventional anti-insulin Ig transgenes (Ig only) derived from mAb 125 on a C57BL/6 background (backcross Ͼ27) and were generated and maintained as described previously (27, 28) . B cells in 125Tg mice show no signs of allelic inclusion (25) and maintain high levels of allelic exclusion for long periods of time (Ͼ30 wk); Ն 95% of B220 ϩ lymphocytes express only IgM a as revealed by staining with anti-IgM a vs anti-IgM b (27, 28) . Nontransgenic (non-Tg) C57BL/6 mice (Taconic Farms) were used as controls. All mice were 8 -12 wks old and were housed under specific pathogen-free conditions. All studies were approved by the Institutional Animal Care and Use Committee of Vanderbilt University (Nashville, TN).
Immunoblotting
Splenic B cells from non-Tg and 125Tg C57BL/6 mice were purified on magnetic beads (Miltenyi Biotec) and were routinely Ͼ90% pure as analyzed by anti-B220 (6B2; BD Pharmingen) Ab staining. Purified B cells were suspended in complete medium as described previously (25, 27) and stimulated (where specified) with 10 g/ml F(abЈ) 2 goat anti-mouse -chain (Jackson ImmunoResearch Laboratories) or 1 M ionomycin (Sigma-Aldrich) for the indicated times. Total cell lysates were prepared in lysis buffer containing 50 mM HEPES (pH 7.5) (Invitrogen Life Technologies), 5% glycerol (Invitrogen Life Technologies), 1% Triton X-100 (Sigma-Aldrich), 1 mM sodium orthovanadate (Sigma-Aldrich), 100 mM sodium chloride (Sigma-Aldrich), and protease inhibitors (Roche Applied Science). Cytoplasmic and nuclear extracts were separated as previously described (29, 30) . Total protein loaded was verified by BCA assay (Pierce). Samples were analyzed by immunoblotting using an ECL system (Amersham Biosciences). Ab reagents purchased from Santa Cruz Biotechnology were reactive with phospho-tyrosine (clone pY99), phosphoLyn (polyclonal), Lyn (polyclonal), phospholipase C (PLC␥2) (polyclonal), NFATc1 (clone 7A6), and G ␤ (polyclonal) (loading control). Abs reactive with phospho-Syk (polyclonal), Syk (polyclonal), and phospho-PLC␥2 (polyclonal) were obtained from Cell Signaling Technology. AntiIgM Ab (polyclonal) was purchased from Chemicon.
Ca 2ϩ mobilization assay
Purified splenic B cells from non-Tg and 125Tg mice were suspended in HBSS (Invitrogen Life Technologies) containing 50 mM HEPES (pH 7.5) and plated on poly-D-lysine-coated glass bottom microwell dishes (MatTek) for 30 min at 37°C. Cells were loaded with the cell-permeant, Ca 2ϩ -sensitive dye fura 2-AM (5 M) (Molecular Probes) for 30 min at room temperature and then washed in HBSS. For some experiments, fura 2-AMloaded cells were suspended initially in Ca 2ϩ -free HBSS (Cambrex) containing 2 mM EGTA (Sigma-Aldrich) that was supplemented with 2 mM CaCl 2 (Sigma-Aldrich) after 5 min. The dishes were mounted on an inverted Nikon TE300 microscope enclosed in a humidified Plexiglas chamber maintained at 37°C with an atmosphere of 5% CO 2 . Images were collected using a ϫ40, 1.3 numerical aperture, oil immersion Plan Fluor objective lens and a side-mounted CoolSNAP HQ camera. Fluorescence was monitored using dual excitation wavelengths (340/380 nm) and a single emission wavelength (510 nm). Fluorescence at 340 nm indicates dye bound to Ca 2ϩ , whereas that at 380 nm corresponds to free dye. Basal readings were taken for 45 s before stimulation. Metamorph imaging software (Universal Imaging) was used for automated collection of images at either 1 or 5 s intervals over a 5-10 min incubation period. During this time, cells maintained healthy morphology. Average fluorescence measurements were determined using Metamorph software. Data are expressed as the ratio of bound:free fura 2-AM fluorescence intensities.
Inositol 1,4,5-trisphosphate (IP 3 ) production analysis
Purified splenic B cells (2 ϫ 10 6 ) from non-Tg and 125Tg mice were suspended in 50 l of complete medium and stimulated with 10 g/ml F(abЈ) 2 goat anti-mouse -chain at 37°C for the times indicated. IP 3 production was determined by Biotrak IP 3 assay system (Amersham Biosciences). Data from three independent experiments are expressed as the ratio of IP 3 levels at each time point over basal IP 3 levels in non-Tg B cells. Error bars represent SEM (Fig. 5) .
Results
Protein p-Tyr is highly active in tolerant anti-insulin B cells following stimulation with anti-IgM
Anti-insulin 125Tg B cells mature normally but are maintained in an anergic state by autologous insulin occupying their BCR (25, 27) . To examine the BCR-derived responses of B lymphocytes that have been rendered tolerant by exposure to physiologic concentrations of insulin in vivo, protein p-Tyr was examined following stimulation with 10 g/ml anti-IgM. This dose is in the recognized optimal range for responses of normal B cells and was used in studies of anergic B cells in other tolerance models to unmask signaling defects in those systems (10, 12) . The kinetics of the p-Tyr response was compared using Western blotting ( lanes 1 and 5 in Fig. 1 ). Within 1 min of stimulation, multiple proteins are phosphorylated in control and 125Tg B cells (Fig. 1 , lanes 2 and 6). Phosphorylation of Lyn and Syk (arrows) was confirmed in separate experiments (not shown). Similarly, there was no difference between non-Tg and 125Tg B cells in phosphorylated phospholipase C (PLC) ␥2 either basally or following BCR stimulation (Fig. 2) . The 125Tg B cells have a relative increase of 1.2 for IgM H chain (not shown). Although the overall p-Tyr response is more robust and of longer duration in 125Tg (Fig. 1 , lanes 6 -8) than in non-Tg B cells (Fig. 1, lanes 2-4) , a longer exposure of the blot (Fig. 1, middle panel) shows that the same molecular mass proteins are targeted by BCR signaling in control and 125Tg B cells. These data are highly reproducible and clearly show that the p-Tyr response is not impaired in tolerant antiinsulin B cells.
Ca 2ϩ response of 125Tg B cells is markedly impaired following treatment with ionophore
Activation of Ag receptors on immune cells normally leads to a rapid change in [Ca 2ϩ ] i via several mechanisms, including Ca 2ϩ release from internal stores and Ca 2ϩ influx across the plasma membrane (9, 31) . In the tolerance models studied to date, anergic B cells are characterized by an increase in basal [Ca 2ϩ ] i and by impaired Ca 2ϩ mobilization following BCR stimulation (5, 6, 11, 12, 32) . Therefore, the ability of non-Tg and 125Tg B cells to mobilize Ca 2ϩ upon stimulation was measured in fura 2-AMloaded cells (Fig. 3) . In all experiments, the relative [Ca 2ϩ ] i under basal conditions (45 s before treatment), was not measurably different between control and 125Tg B cells (n ϭ 12). Following stimulation with 10 g/ml anti-IgM (Fig. 3 , third panel from the top; indicated by arrow), control and 125Tg B cells generated a Ca 2ϩ flux of similar magnitude and duration. At suboptimal doses of anti-IgM (1 g/ml), non-Tg B cells had a slightly higher Ca 2ϩ response than 125Tg B cells (Fig. 3, second panel from the top) . Non-Tg B cells treated with 5 M ionomycin (Fig. 3 , bottom panel) generated a steep rise in intracellular Ca 2ϩ immediately following stimulation that was sustained for the duration of the experiment. The magnitude of the Ca 2ϩ response to ionomycin in non-Tg B cells was greater than that evoked following BCR crosslinking. In striking contrast, when tolerant 125Tg B cells were treated with 5 M ionomycin the magnitude of the Ca 2ϩ flux was reduced compared with that of non-Tg B cells (Fig. 3, bottom  panel) . This response, however, was also sustained for the duration of the experiment. The Ca 2ϩ response of 125Tg B cells was also impaired at lower doses of ionophore (not shown). These results indicate that the capacity of tolerant anti-insulin B cells to flux Ca 2ϩ in response to treatment with either ionophore or 1 g/ml anti-IgM is impaired even though their ability to mobilize Ca 2ϩ following 125Tg BCR cross-linking with 10 g/ml anti-IgM appears to be preserved.
Impaired Ca 2ϩ release localizes to the endoplasmic reticulum (ER) in anti-insulin 125Tg B cells
Increases in intracellular Ca 2ϩ arise from two sources, release from intracellular stores in the ER, and through channels in the cell membrane that permit Ca 2ϩ to move from the extracellular environment into the cell (9, 31). Therefore, the impaired Ca 2ϩ response of 125Tg B cells could be the result of diminished Ca 2ϩ FIGURE 2. PLC␥2 phosphorylation (p-PLC␥2) is normal in 125Tg B cells. Non-Tg (lanes 1-4) and 125Tg (lanes 5-8) B cells were stimulated with 10 g/ml F(abЈ) 2 goat anti-mouse IgM for the indicated times and subjected to immunoblotting (4 g of total protein per lane) with Abs to phospho-PLC␥2, PLC␥2, and G ␤ (loading control). p-PLC␥2 levels were normalized to the loading control and are indicated immediately below the blot. mobilization across the ER, failure to induce Ca 2ϩ influx from extracellular sources across the plasma membrane, or both. To distinguish between these possibilities, we measured the Ca 2ϩ response of non-Tg and 125Tg B cells following stimulation in Ca 2ϩ -free buffer that was subsequently supplemented with 2 mM CaCl 2 . In this way, the initial Ca 2ϩ release from internal stores can be separated from the ensuing Ca 2ϩ influx across the plasma membrane. When control B cells were treated with 10 g/ml anti-IgM in the absence of Ca 2ϩ (Fig. 4, top panel; solid arrow) , an increase in fura 2-AM fluorescence indicative of free Ca 2ϩ released from the ER was observed. Following the addition of Ca 2ϩ to the medium (open arrow), [Ca 2ϩ ] i increased further and was sustained for the duration of the experiment. In contrast, anti-IgM stimulation of 125Tg B cells in the absence of Ca 2ϩ (Fig. 4, top panel) When similar experiments were performed using ionomycin (Fig. 4, middle panel) Fig. 4, top and middle panels) . Likewise, under Ca 2ϩ -free conditions 125Tg B cells generated a measurable Ca 2ϩ response from the ER and from the extracellular medium following ionomycin treatment. However, the overall magnitude of the Ca 2ϩ flux induced by ionomycin in 125Tg B cells was reduced relative to non-Tg B cells under these conditions. These findings suggest that the ER Ca 2ϩ response of 125Tg B cells is altered, whereas their ability to flux extracellular Ca 2ϩ remains intact.
One mechanism regulating ER Ca 2ϩ release is the activity of the sarco-endoplasmic Ca 2ϩ -ATPase (SERCA), which mediates the reuptake of Ca 2ϩ from the cytoplasm into the ER. In the absence of Ca 2ϩ , the ATPase activity of SERCA is low, leading to a slow leak of Ca 2ϩ from intracellular stores (33, 34) . In addition, inhibition of SERCA activity by the drug thapsigargin results in an increase in [Ca 2ϩ ] i that reflects Ca 2ϩ release from ER stores. Accordingly, the Ca 2ϩ response of non-Tg and 125Tg B cells to thapsigargin was examined. Treatment with thapsigargin induced greater Ca 2ϩ release from the ER in 125Tg B cells than in control B cells (Fig. 4, bottom panel) . This increased responsiveness to thapsigargin treatment generates a small but consistently higher level of extracellular Ca 2ϩ influx in 125Tg B cells relative to control B cells when Ca 2ϩ is returned to the medium. These data, together with the impaired sensitivity to anti-IgM and ionomycin treatment, suggest that increased SERCA activity in 125Tg B cells maintains normal [Ca 2ϩ ] i in tolerant B cells by altering the threshold of ER responses.
IP 3 metabolism is altered in tolerant anti-insulin B cells
BCR-derived signals lead to the production of IP 3 which, upon binding to its receptor (IP 3 R) in the ER, induces the release of stored Ca 2ϩ (35) . Therefore, IP 3 generation was measured in non-Tg and 125Tg B cells (Fig. 5) . The data reveal that basal IP 3 levels are elevated 3.5-fold in anti-insulin 125Tg B cells compared with control B cells. Upon BCR engagement for 1 min, generation of IP 3 is increased 2.5-fold over basal levels in control B cells but only 12.5% in 125Tg B cells. After 3 min of BCR stimulation, non-Tg B cells increased IP 3 production 3-fold over basal levels, whereas 125Tg B cells increased IP 3 generation only 20%. These data indicate that basal IP 3 production is elevated in anti-insulin 125Tg B cells and that the ability of anti-IgM to increase BCRinduced generation of IP 3 is impaired in 125Tg B cells relative to non-Tg B cells. 
Basal NFATc1 levels are reduced in anti-insulin 125Tg B cells
The transcription factor NFAT is a key downstream mediator of BCR-dependent signaling that is dependent upon Ca 2ϩ mobilization. In T cells induced to become anergic by prolonged ionomycin treatment, the genetic regulation of anergy appears to be governed by the availability of different NFATs (36) . Therefore, basal NFATc1 levels were analyzed by Western blotting (Fig. 6 ) in total extracts prepared from freshly isolated B cells from individual non-Tg (lanes 1-4) and 125Tg (lanes 5-8) mice. B cells from non-Tg mice express significantly higher (3.6-fold) NFATc1 levels than those of mice harboring 125Tg (1.74 Ϯ 0.81 vs 0.49 Ϯ 0.25, p ϭ 0.025 by Student's t test). These data show that NFATc1 expression is reduced in anti-insulin B cells and suggest that NFAT availability might play a role in regulating tolerance in 125Tg B cells.
Anti-insulin 125Tg B cells fail to activate NFATc1
NFAT activation was analyzed by Western blotting following stimulation of non-Tg and anti-insulin 125Tg B cells with antiIgM. Translocation of NFATc1 from the cytoplasm into the nucleus was readily detected following BCR cross-linking in non-Tg B cells (Fig. 7, lanes 1-3; ϳ90 -96% depletion from cytoplasm). In contrast, NFATc1 translocation was not detectable above basal levels in 125Tg B cells after 30 min of anti-IgM stimulation ( Fig. 7) . However, in 125Tg B cells ionomycin treatment resulted in a markedly reduced translocation of cytoplasmic NFATc1 into the nucleus (50% depletion from cytoplasm; compare lane 5 to lane 8 in Fig. 7 ) relative to control B cells. The inability to initiate nuclear translocation of NFATc1 in 125Tg B cells is consistent with the altered intracellular mobilization of Ca 2ϩ that we find using these same stimuli in tolerant 125Tg B cells.
Discussion
B cells that harbor anti-insulin 125Tg are functionally tolerant, as manifested by their failure to respond to immunization in vivo and by anergy to BCR stimulation in vitro (25, 27) . Although similar functional impairments are present in other models of tolerance, anti-insulin B cells complete peripheral maturation and, thus, contrast the usual association of anergy with arrested development. This study investigates the nature of intracellular signals that maintain tolerance in anti-insulin B cells. When conventional BCR stimulation is used (10 g/ml F(abЈ) 2 anti-IgM), 125Tg BCR-mediated signals are not uncoupled from p-Tyr (Figs. 1 and 2) , and total cellular Ca 2ϩ fluxes appear normal (Fig. 3) . These findings contrast the responses in tolerance models associated with altered peripheral development (8, (15) (16) (17) (18) in which protein p-Tyr and Ca 2ϩ mobilization dynamics are both abnormal. Thus, anergy is maintained in 125Tg B cells without the severe impairments in BCR signaling that are associated with models of anergy published to date. However, 125Tg B cells differ from control B cells when total Ca 2ϩ flux is measured following suboptimal BCR stimulation and when B cells are stimulated with ionomycin (Fig. 3) .
Although (Fig. 5) , impaired Ca 2ϩ mobilization from internal stores following optimal BCR stimulation (Fig. 4) , and both impaired NFATc1 production and impaired NFATc1 activation (Figs. 6 and 7) . These findings indicate that 125Tg BCR occupancy by insulin generates signals that can sustain tolerance without altering peripheral development and without profound changes in BCR-associated tyrosine kinase activity. The more severe impairments in BCR signaling in other models of tolerance, including anti-HEL, are likely reflected in the B cell development block observed in these systems. A critical difference in tolerance between 125Tg B cells and B lymphocytes in other models such as anti-HEL/HEL resides in the way Ag availability is regulated. In the anti-HEL model auto-Ag levels are fixed, whereas for antiinsulin B cells Ag levels fluctuate according to the physiologic regulation of glucose concentration. Thus, hormone removed from circulation by binding to anti-insulin BCRs is quickly replaced so that Ag is continuously available. Our findings that most 125Tg BCRs are occupied by insulin (27) are consistent with this process. Thus, our data indicate that anergy is not a fixed state but a continuum of alterations that result from quantitative and qualitative changes in BCR signaling.
A previously unrecognized feature of tolerance that we find in anti-insulin B cells is impaired Ca 2ϩ release from intracellular stores (Fig. 4) . One indication of impaired Ca 2ϩ mobilization in 125Tg B cells is their blunted response to ionomycin (Fig. 3) , an 1-4) and 125Tg (lanes 5-8) mice and were subjected to immunoblotting (4 g of total protein per lane) using antiNFATc1 and anti-G ␤ Abs (loading control). NFATc1 levels were normalized to the loading control and are indicated immediately below the blot. 1-4) and 125Tg (lanes  5-8) B cells were treated with either 10 g/ml F(abЈ) 2 goat anti-mouse IgM (lanes 2-3, and 6 -7) for the indicated times or with 1 M ionomycin (lanes 4 and 8) for 30 min. Cytoplasmic (4 g of total protein per lane) and nuclear (2 g of total protein per lane) extracts were prepared and subjected to immunoblotting using anti-NFATc1 and anti-G ␤ Abs (loading control). NFATc1 levels were normalized to the loading control and are indicated immediately below each blot.
agent commonly used as a positive control in Ca 2ϩ studies. Previous work in T cells selected for signaling defects found that resistance to ionomycin-induced intracellular Ca 2ϩ elevation can be due to failure to evoke Ca 2ϩ mobilization across the plasma membrane (37) . In contrast, experiments using ionomycin or antiIgM in the absence of extracellular Ca 2ϩ reveal that impaired Ca 2ϩ release in 125Tg B cells is due to a failure to mobilize Ca 2ϩ from intracellular stores (Fig. 4) . Unlike the response to treatment with 5 M ionomycin, the total Ca 2ϩ response of 125Tg B cells is not markedly impaired following stimulation with 10 g/ml antiIgM (Fig. 3) . This outcome may reflect the numerous signals generated by extensive BCR cross-linking compared with ionomycin, which may directly target the ER (38) . An attenuated ER response to anti-IgM is unmasked when the availability of extracellular Ca 2ϩ is restricted (Fig. 4, top panel) . This finding suggests that, under normal Ca 2ϩ conditions, a large Ca 2ϩ influx across the plasma membrane obscures an impaired ER Ca 2ϩ response of 125Tg B cells following treatment with 10 g/ml anti-IgM (Fig. 3,  top panel) . Only a small intracellular signal (as revealed in Fig. 4 , top panel) is needed to trigger this influx of extracellular Ca 2ϩ , which buries the small peak corresponding to release of intracellular Ca
2ϩ . These observations demonstrate that processes tightly regulating intracellular Ca 2ϩ signals are connected to the tolerant state in anti-insulin B cells. Consistent with this idea, recent studies suggest that persistent BCR occupancy by self-Ag is required for maintaining impaired Ca 2ϩ mobilization and the anergic state in an Ig transgenic model in which B cells specific for a hapten (arsonate) cross-react with an auto-Ag (39) . Our data further indicate that the tolerant state of anti-insulin B cells can be overcome, consistent with the loss of tolerance to insulin as occurs in autoimmune (type 1) diabetes and after insulin therapy.
In B cells, binding of IP 3 to its receptor on the ER membrane is the primary means of inducing Ca 2ϩ release following BCR stimulation. Ca 2ϩ and IP 3 regulate the Ca 2ϩ channel activity of IP 3 R in a biphasic manner so that elevated levels of either Ca 2ϩ or IP 3 in the cytoplasm will also inhibit Ca 2ϩ release from ER stores (40 -42) . In addition, removal of IP 3 is an active process (43) (44) (45) that may be impaired in the tolerant state. Thus, the high basal levels of IP 3 found in 125Tg B cells (Fig. 5) are likely to play a role in attenuating ER Ca 2ϩ release in response to ionomycin and following anti-IgM stimulation. In forms of tolerance induced by high affinity interactions such as anti-HEL/HEL, elevated levels of free intracellular Ca 2ϩ may play a similar role in dampening Ca 2ϩ responses (9, 10) . Understanding how BCR occupancy with paucivalent ligands, such as insulin, lead to sustained IP 3 levels is an important issue for future studies.
Further insight into the mechanisms maintaining Ca 2ϩ homeostasis in 125Tg B cells is provided by the use of thapsigargin to inhibit SERCA activity (Fig. 5, bottom panel) . More Ca 2ϩ is released in response to thapsigargin treatment by 125Tg B cells than by non-Tg B cells, suggesting that SERCA expression and/or activity is augmented in anergic B cells. Increased SERCA activity may explain why basal Ca 2ϩ levels are normal in 125Tg B cells rather than elevated as in other tolerance models. Because insulin binding to the 125Tg BCR does not extensively cross-link surface IgM, it is likely that under basal conditions there is only a modest increase in ER Ca 2ϩ release that is compensated for by higher total SERCA activity. Therefore, the increased [Ca 2ϩ ] i observed in the high affinity tolerance models may reflect the inability of those cells to compensate for the augmented Ca 2ϩ load induced by more intense BCR stimulation.
Our findings of normal levels of p-PLC␥2 (Fig. 2) are unexpected given the elevated IP 3 production in 125Tg B cells. However, the phosphorylation status of PLC␥ does not necessarily reflect all of its activity (45, 46) . Thus, it is possible that fine differences in the activation state of PLC␥2, not revealed by phosphorylation, contribute to the impaired Ca 2ϩ response of 125Tg B cells. Studies in PLC␥2-deficient B cells have indicated that lipaseindependent PLC␥2 activities may have a role in BCR-dependent Ca 2ϩ responses (47) . Furthermore, Cbl proteins, known to negatively regulate BCR signaling in part by directing Syk kinase degradation (48) , can also target PLC␥2 (49) , suggesting that protein turnover and/or recruitment could be altered in tolerant B cells.
A feature of anergy in 125Tg B cells that is shared with other tolerance models is the dysregulated activation of NFAT. The impaired Ca 2ϩ response of 125Tg B cells is associated with increased basal levels of nuclear NFATc1 and with failure to induce further translocation of NFATc1 from the cytoplasm into the nucleus following stimulation with either anti-IgM or ionomycin (Fig. 7) . Although a similar outcome is also observed in the anti-HEL system (9, 10), the block in NFATc1 translocation, especially in response to ionomycin, is much more severe in anti-insulin 125Tg cells. Furthermore, no defect in total NFAT levels were reported in tolerant anti-HEL B cells. In contrast, we have found a significant reduction (3.6-fold) in total NFATc1 expression in 125Tg B cells (Fig. 6) , suggesting that the amount of NFAT available for induction might be limited in these cells. This finding suggests that the inability of anti-insulin B cells to proliferate in response to antiIgM stimulation in vitro (25) may be linked to impairments of nuclear NFAT activity. Studies in other systems suggest that NFAT proteins play a key role in regulating cell cycle progression (50, 51) . In addition, in T cells induced to become anergic by prolonged ionomycin treatment, the genetic regulation of anergy appears to be governed by the availability of different nuclear NFATs (36) . Such similarities in diverse systems suggest that altered expression and induction of NFATs, and possibly other transcription factors, may play a common role in silencing autoimmune responses.
It is possible that the hormone receptor for insulin (InsR) could have a role in insulin immunity and tolerance. However, we do not detect differences in 125Tg B cell responses when either hormonally active or inactive insulin is used (not shown). In addition, previous studies have shown that mAb125 does not recognize InsR-bound insulin (52) and that resting T and B cells do not express InsR (53) . However, both BCR and InsR traffic in clathrin vesicles; thus, it remains possible that some interactions in the endosomal pathway generate signals during intracellular processing. Studies are in progress to explore this possibility.
Our findings are consistent with a model (Fig. 8 ) in which continuous BCR occupancy by insulin alters normal basal signaling and triggers compensatory mechanisms that lead to impaired Ca 2ϩ mobilization (Fig. 4) and decreased NFAT activity (Fig. 7) . This attenuated Ca 2ϩ response is not associated with the uncoupling of 125Tg BCR from downstream signaling pathways, because overall p-Tyr is intact (Fig. 1) . Instead, signaling from an occupied BCR may lead to heightened SERCA activity (Fig. 4) and contribute to the impaired Ca 2ϩ response by elevating basal IP 3 levels (Fig. 6 ) that may further impair Ca 2ϩ release. Another possibility is that the decreased ER Ca 2ϩ response in 125Tg B cells might be regulated at the level of the IP 3 R, thus altering the action of Ca 
